These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25702678)

  • 1. Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: efficacy of octreotide and tamoxifen.
    Biasco E; Antonuzzo A; Galli L; Baldi GG; Derosa L; Marconcini R; Farnesi A; Ricci S; Falcone A
    Tumori; 2015 Mar; 101(1):e24-8. PubMed ID: 25702678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined surgical intervention and medical management in a case of atypical idiopathic retroperitoneal fibrosis.
    Saheed MC; Ginilkumar P; Sanjeevan KV; Bhat SH
    Int J Urol; 2006 Mar; 13(3):291-3. PubMed ID: 16643628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal fibrosis: a rare cause of both ureteral and small bowel obstruction.
    Aziz F; Conjeevaram S; Phan T
    World J Gastroenterol; 2006 Nov; 12(43):7061-3. PubMed ID: 17109508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.
    Bajetta E; Catena L; Fazio N; Pusceddu S; Biondani P; Blanco G; Ricci S; Aieta M; Pucci F; Valente M; Bianco N; Mauri CM; Spada F
    Cancer; 2014 Aug; 120(16):2457-63. PubMed ID: 24752410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen in the treatment of idiopathic retroperitoneal fibrosis.
    Ergun I; Keven K; Canbakan B; Ekmekci Y; Erbay B
    Int Urol Nephrol; 2005; 37(2):341-3. PubMed ID: 16142568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe back and abdominal pain in a 44-year-old woman.
    Jaffer A; Calabrese L
    Cleve Clin J Med; 1998; 65(10):515-8. PubMed ID: 9830784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
    Frank M; Klose KJ; Wied M; Ishaque N; Schade-Brittinger C; Arnold R
    Am J Gastroenterol; 1999 May; 94(5):1381-7. PubMed ID: 10235222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it time to widen the use of somatostatin analogs in neuroendocrine tumors?
    Oberg KE
    J Clin Oncol; 2009 Oct; 27(28):4635-6. PubMed ID: 19704053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Idiopathic retroperitoneal fibrosis: unusual cause of abdominal pain. A case report].
    Janssen N; D'Orio V
    Rev Med Liege; 2006; 61(7-8):548-52. PubMed ID: 17020226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regression of retroperitoneal fibrosis by combination therapy with tamoxifen and steroids].
    Allendorff J; Riegel W; Köhler H
    Med Klin (Munich); 1997 Jul; 92(7):439-43. PubMed ID: 9324631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic retroperitoneal fibrosis (Ormond's disease)].
    Nelius T; Reiher F; Lindenmeir T; Kalinski T; Rau O; Filleur S; Allhoff EP
    Aktuelle Urol; 2006 Jul; 37(4):284-8. PubMed ID: 16878283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis.
    Strosberg JR; Yao JC; Bajetta E; Aout M; Bakker B; Hainsworth JD; Ruszniewski PB; Van Cutsem E; Öberg K; Pavel ME
    Endocr Relat Cancer; 2015 Dec; 22(6):933-40. PubMed ID: 26373569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of idiopathic sclerosing mesenteritis with retroperitoneal fibrosis].
    Bae JH; Kim SH; Ahn SB; Son BK; Jo YJ; Park YS; Jung YM; Chang YS
    Korean J Gastroenterol; 2011 Oct; 58(4):221-5. PubMed ID: 22042424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureteral obstruction due to retroperitoneal fibrosis secondary to a solitary internal iliac aneurysm.
    Mineta K; Nomura M; Fujimoto N; Takahashi K; Matsumoto T
    Int J Urol; 2004 Nov; 11(11):1024-7. PubMed ID: 15509210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of ureteric obstruction, retroperitoneal fibrosis, and carcinoid tumour.
    Dev S; al-Dujaily S; Subbuswamy SG
    Postgrad Med J; 1999 Jan; 75(879):38-40. PubMed ID: 10396587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
    Rinke A; Müller HH; Schade-Brittinger C; Klose KJ; Barth P; Wied M; Mayer C; Aminossadati B; Pape UF; Bläker M; Harder J; Arnold C; Gress T; Arnold R;
    J Clin Oncol; 2009 Oct; 27(28):4656-63. PubMed ID: 19704057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological therapy of neuroendocrine tumors.
    Rinke A; Ricci S; Bajetta E; Jelic S
    Tumori; 2010; 96(5):847-57. PubMed ID: 21302642
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudocyst formation in retroperitoneal fibrosis relapse.
    Jansen I; Hendriksz TR; Van Bommel EF
    Br J Radiol; 2010 Jun; 83(990):e111-3. PubMed ID: 20505023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen].
    Wenger FA; Zieren HU; Jacobi CA; Müller JM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1348-50. PubMed ID: 9931878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.